Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum MedMira Inc MMIRF


Primary Symbol: V.MIR

MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely... see more

TSXV:MIR - Post Discussion

MedMira Inc > JUST MAYBE YEAR END ACCOUNT IS BAD !
View:
Post by august202013 on Sep 26, 2023 3:01pm

JUST MAYBE YEAR END ACCOUNT IS BAD !

COULD BE SOME WITH PRIVILEGE INFORMATION ARE UNLOADING JUST BEFORE RELEASE OF ACCOUNTS. IT'S MARKET MANIPULATION !
COULD BE CHARGED. REALLY SERIOUS OFFENCE AND COULD BE JAILED. HOPE ANYONE DOING IT KNOWS IT.

NO WORRIES ANY PO FROM H .......C.. COULD EXTINGUISHED ANY LOSSES SIMPLY BECAUSE OF REVENUE STREAM AKA CASH FLOW. OTHERS SHOULD FOLLOW INCLUDING INSTITUTIONAL INVESTORS. ONLY IF/AFTER PO ?

STILL WAITING
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities